Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 17/20 | 0.51 |
| ▸ | EDNRB | P24530 | 10/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7849759 | 1.00 | EDNRA (0.51) | EDNRAEDNRBMEN1CYP2C9TSHR | |
| SCHEMBL7856775 | 0.89 | EDNRA (0.53) | EDNRAEDNRB | |
| SCHEMBL7856725 | 0.80 | EDNRA (0.59) | EDNRAEDNRB | |
| SCHEMBL7856744 | 0.79 | EDNRA (0.61) | EDNRAEDNRB | |
| SCHEMBL7857431 | 0.79 | CYP19A1 (0.39) | MEN1KMT2A | |
| SCHEMBL6771184 | 0.77 | EDNRA (0.68) | EDNRAEDNRB | |
| SCHEMBL7858322 | 0.74 | EDNRA (0.53) | EDNRAEDNRBMEN1CYP2C9TSHR | |
| SCHEMBL6771735 | 0.74 | EDNRA (0.67) | EDNRAEDNRB | |
| SCHEMBL20699838 | 0.71 | MAPT (0.57) | MEN1KMT2A | |
| SCHEMBL22529451 | 0.71 | MAPK1 (0.50) | EDNRAEDNRBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1069114-A2 | Sulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2001-01-17 | — | — | EP | claimed |
| EP-0870764-A1 | Sulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-10-14 | — | — | EP | claimed |
| EP-1069114-A2 | Sulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2001-01-17 | — | — | EP | disclosed |
| EP-0870764-A1 | Sulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-10-14 | — | — | EP | disclosed |
| US-5571821-A | CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-11-05 | — | — | US | disclosed |